Group 1: Core Competitiveness - The company has integrated capabilities in formulation, active ingredients, and intermediates, excelling in R&D, engineering, production, and sales [3] - The product range is diverse, with a focus on developing major formulations to meet market demands, particularly in pest and weed control [3] - The R&D team is well-structured, covering all aspects of pesticide development, making it one of the most comprehensive pesticide R&D centers in China [3] Group 2: Overseas Business Expansion - The company is actively expanding its overseas business, guided by a "domestic and international integration" strategy [4] - Efforts include enhancing the operational team for international markets and strengthening partnerships with multinational companies [4] Group 3: Product Performance and Sales - In the first three quarters, pesticide sales increased by 2%, while fertilizer sales surged by 60.87% [5] - Average selling prices for pesticides decreased by 15.63%, leading to a 13.95% decline in revenue, while fertilizer revenue grew by 27.35% [5] Group 4: Future Product Development - The company plans to launch 12 new active ingredients within the next three years, with ongoing testing for several compounds [6] - The production capacity for the fungicide Pyraclostrobin is expected to reach 15,000 tons, enhancing market competitiveness [4] Group 5: Financial Performance and Challenges - The company faced a decline in net profit and revenue in recent quarters due to market price drops and seasonal sales fluctuations [6] - The total investment in the Hengning project is substantial, with ongoing efforts to improve operational efficiency and product output [6] Group 6: Shareholder Value and Future Plans - The company has distributed approximately 850 million in dividends over the past three years, with a focus on enhancing core competitiveness to create more value for investors [7] - There are no immediate plans for refinancing, and stakeholders are encouraged to monitor company announcements for updates [7]
海利尔(603639) - 投资者关系活动记录表(2024年11月28日)